Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science Investigations

110mIn-DTPA-d-Phe1-Octreotide for Imaging of Neuroendocrine Tumors with PET

Mark Lubberink, Vladimir Tolmachev, Charles Widström, Alexander Bruskin, Hans Lundqvist and Jan-Erik Westlin
Journal of Nuclear Medicine October 2002, 43 (10) 1391-1397;
Mark Lubberink
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vladimir Tolmachev
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Widström
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Bruskin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Lundqvist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan-Erik Westlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

FIGURE 1.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Spatial resolution in PET and SPECT with 110mIn and 111In, respectively. Just outside FOV in SPECT measurement was 20-cm point. FWHM = full width at half maximum.

  View article

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FIGURE 1.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
110mIn-DTPA-d-Phe1-Octreotide for Imaging of Neuroendocrine Tumors with PET
Mark Lubberink, Vladimir Tolmachev, Charles Widström, Alexander Bruskin, Hans Lundqvist, Jan-Erik Westlin
Journal of Nuclear Medicine Oct 2002, 43 (10) 1391-1397;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
110mIn-DTPA-d-Phe1-Octreotide for Imaging of Neuroendocrine Tumors with PET
Mark Lubberink, Vladimir Tolmachev, Charles Widström, Alexander Bruskin, Hans Lundqvist, Jan-Erik Westlin
Journal of Nuclear Medicine Oct 2002, 43 (10) 1391-1397;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire